QUADRANT CAPITAL GROUP LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,180
+618.0%
689
+1540.5%
0.00%
Q2 2023$1,975
-24.1%
42
-32.3%
0.00%
Q1 2023$2,602
+62.4%
62
+47.6%
0.00%
Q4 2022$1,602
-46.6%
42
-37.3%
0.00%
Q3 2022$3,000
+50.0%
670.0%0.00%
Q2 2022$2,000
+100.0%
67
+168.0%
0.00%
Q1 2022$1,000
-66.7%
25
-57.6%
0.00%
Q4 2021$3,000
+200.0%
59
+110.7%
0.00%
Q3 2021$1,000
-66.7%
28
-53.3%
0.00%
Q2 2021$3,000
-40.0%
60
-13.0%
0.00%
-100.0%
Q1 2021$5,000
-28.6%
69
-14.8%
0.00%0.0%
Q4 2020$7,000
+75.0%
81
+22.7%
0.00%0.0%
Q3 2020$4,000
+300.0%
66
+164.0%
0.00%
Q2 2020$1,000
-66.7%
25
-77.3%
0.00%
-100.0%
Q1 2020$3,000110
+1471.4%
0.00%
Q4 2019$0
-100.0%
7
-96.0%
0.00%
-100.0%
Q3 2019$23,000
-62.9%
176
-49.4%
0.00%
-60.0%
Q2 2019$62,000
+17.0%
3480.0%0.01%
+11.1%
Q1 2019$53,000348
+4871.4%
0.01%
Q4 2018$070.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders